PBLA Projected Dividend Yield
Panbela Therapeutics Inc (New) ( OTCBB : PBLA )Panbela Therapeutics is a clinical stage biopharmaceutical company developing therapeutics for the treatment of patients with cancer. Co.'s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition, a metabolic pathway of critical importance in multiple tumor types. 20 YEAR PERFORMANCE RESULTS |
PBLA Dividend History Detail PBLA Dividend News PBLA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |